Egle Therapeutics has been founded with a vision to become a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Tregs’ starving while specifically targeting the most immunosuppressive ones.
Company Details
- Employees
- 48
- Founded
- -
- Address
- Paris, Fr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.egle-tx.com
- HQ
- Paris
Egle Therapeutics Questions
Egle Therapeutics's website is http://www.egle-tx.com
Egle Therapeutics's LinkedIn profile is https://fr.linkedin.com/company/egle-tx
Egle Therapeutics has
48 employees.
View email and phone details for 48
employees at Egle Therapeutics.
Egle Therapeutics's industry is
Biotechnology Research
Egle Therapeutics's top competitors are
Candid Therapeutics,
Acticor Biotech,
Cellectis,
Peptinov,
Mnemo Therapeutics,
Hifibio Therapeutics,
Abivax,
Ose Immunotherapeutics,
Innate Pharma,
Pep-Therapy.
Egle Therapeutics's categories are Biotechnology Research
Egle Therapeutics's founding year is 2020
